Drug name - Airduo Digihaler
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7540282 | TEVA PHARM | Reservoir pressure system for medicament inhaler |
May, 2023
(7 months from now) | |
|
US7540282
(Pediatric) | TEVA PHARM | Reservoir pressure system for medicament inhaler |
Nov, 2023
(1 year, 1 month from now) | |
| US9616024 | TEVA PHARM | Process for preparing a medicament |
Sep, 2024
(1 year, 11 months from now) | |
| US9987229 | TEVA PHARM | Process for preparing a medicament |
Sep, 2024
(1 year, 11 months from now) | |
|
US9616024
(Pediatric) | TEVA PHARM | Process for preparing a medicament |
Mar, 2025
(2 years from now) | |
|
US9987229
(Pediatric) | TEVA PHARM | Process for preparing a medicament |
Mar, 2025
(2 years from now) | |
| US9463288 | TEVA PHARM | Dry powder inhalation apparatus |
May, 2025
(2 years from now) | |
| US10765820 | TEVA PHARM | Dry powder inhalation apparatus |
May, 2025
(2 years from now) | |
|
US9463288
(Pediatric) | TEVA PHARM | Dry powder inhalation apparatus |
Nov, 2025
(3 years from now) | |
|
US10765820
(Pediatric) | TEVA PHARM | Dry powder inhalation apparatus |
Nov, 2025
(3 years from now) | |
| US8651103 | TEVA PHARM | Dry powder inhalation apparatus |
Mar, 2028
(5 years from now) | |
|
US8651103
(Pediatric) | TEVA PHARM | Dry powder inhalation apparatus |
Sep, 2028
(6 years from now) | |
| US10195375 | TEVA PHARM | Airflow adaptor for a breath-actuated dry powder inhaler |
Feb, 2031
(8 years from now) | |
| US10022510 | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
May, 2031
(8 years from now) | |
| US9731087 | TEVA PHARM | Dose counter for inhaler having a bore and shaft arrangement |
May, 2031
(8 years from now) | |
| US10124131 | TEVA PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
May, 2031
(8 years from now) | |
| US9216260 | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Jun, 2031
(8 years from now) | |
|
US10195375
(Pediatric) | TEVA PHARM | Airflow adaptor for a breath-actuated dry powder inhaler |
Aug, 2031
(8 years from now) | |
|
US10022510
(Pediatric) | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Nov, 2031
(9 years from now) | |
|
US9731087
(Pediatric) | TEVA PHARM | Dose counter for inhaler having a bore and shaft arrangement |
Nov, 2031
(9 years from now) | |
|
US10124131
(Pediatric) | TEVA PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
Nov, 2031
(9 years from now) | |
|
US9216260
(Pediatric) | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Dec, 2031
(9 years from now) | |
| US10561808 | TEVA PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
Jan, 2032
(9 years from now) | |
| US8978966 | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Jan, 2032
(9 years from now) | |
| US8714149 | TEVA PHARM | Airflow adaptor for a breath-actuated dry powder inhaler |
Feb, 2032
(9 years from now) | |
|
US10561808
(Pediatric) | TEVA PHARM | Dose counter for inhaler having an anti-reverse rotation actuator |
Jul, 2032
(9 years from now) | |
|
US8978966
(Pediatric) | TEVA PHARM | Dose counters for inhalers, inhalers and methods of assembly thereof |
Jul, 2032
(9 years from now) | |
|
US8714149
(Pediatric) | TEVA PHARM | Airflow adaptor for a breath-actuated dry powder inhaler |
Aug, 2032
(9 years from now) | |
| US9066957 | TEVA PHARM | Dry powder inhaler |
Oct, 2034
(12 years from now) | |
| US9415008 | TEVA PHARM | Dry powder inhaler |
Oct, 2034
(12 years from now) | |
|
US9415008
(Pediatric) | TEVA PHARM | Dry powder inhaler |
Apr, 2035
(12 years from now) | |
|
US9066957
(Pediatric) | TEVA PHARM | Dry powder inhaler |
Apr, 2035
(12 years from now) | |
| US9782551 | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Aug, 2035
(12 years from now) | |
| US9782550 | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Aug, 2035
(12 years from now) | |
| US10918816 | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Dec, 2035
(13 years from now) | |
|
US9782551
(Pediatric) | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Feb, 2036
(13 years from now) | |
|
US9782550
(Pediatric) | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Feb, 2036
(13 years from now) | |
|
US10918816
(Pediatric) | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Jun, 2036
(13 years from now) | |
| US10569034 | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Aug, 2036
(13 years from now) | |
|
US10569034
(Pediatric) | TEVA PHARM | Compliance monitoring module for a breath-actuated inhaler |
Feb, 2037
(14 years from now) | |
| US11000653 | TEVA PHARM | Inhaler |
Dec, 2038
(16 years from now) | |
|
US11000653
(Pediatric) | TEVA PHARM | Inhaler |
Jun, 2039
(16 years from now) | |
| US11173259 | TEVA PHARM | Drug delivery device with electronics and power management |
Jul, 2040
(17 years from now) | |
Drugs and Companies using FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE ingredient
Treatment: Treatment of asthma
Dosage: POWDER;INHALATION
| Strength | Dosage | Availability |
|---|---|---|
| 0.055MG/INH;EQ 0.014MG BASE/INH | POWDER;INHALATION | Prescription |
| 0.113MG/INH;EQ 0.014MG BASE/INH | POWDER;INHALATION | Prescription |
| 0.232MG/INH;EQ 0.014MG BASE/INH | POWDER;INHALATION | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.